Skip to main content

Practice Tips

  • Ritzman broadens scope of 'Ritzman Revives' program

    MEDINA, Ohio —  As an answer to a dated, commoditized pharmacy experience, Ritzman Pharmacy is launching new products and services to better align with the actual role pharmacists play in the lives and wellness of patients with a series of comprehensive wellness assessments, the Ohio retailer announced Friday.

  • FDA approves Lilly’s breast cancer drug Verzenio

    SILVER SPRING, Md. — Eli Lilly’s new treatment for certain breast cancers has been approved by the Food and Drug Administration. Verzenio (abemaciclib) was approved to as a treatment for patients with a hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is advanced or metastatic and has progressed following endocrine therapy.

  • Patient ID verification offers untapped potential in the battle against addiction

    I recently read an interesting Washington Post article about efforts to prevent people from abusing pain-killers prescribed for their pets. In response to this disturbing trend, states like Colorado and Maine have passed laws allowing or requiring veterinarians to check the prescription histories of pet owners.

  • Health Mart to host fifth year of revenue-boosting meetings for independents

    IRVING, Texas – Offering independent pharmacies practical advice for taking care of patients and growing their businesses, Health Mart on Tuesday kicked off its fifth Town Hall Continuing Education series titled “Revenue Remedies: Inject Profits into Your Business with Expanded Partnerships and Clinical Services.” Health Mart, with more than 4,800 locally owned community pharmacies across all 50 states, will host more than 80 events across the country through early 2018.

  • Lupin’s generic Clobex lotion gets FDA approval

    SILVER SPRING, Md. — Lupin is adding to its topical generics portfolio. The Food and Drug Administration has approved Lupin’s generic of Galderma Laboratories’ Clobex (clobetasol propionate, 0.05%) lotion, the company announced Tuesday.

    The product is indicated to relieve various corticosteroid-responsive dermatoses in patients ages 18 years and older. For the 12 months ended June 2017, the drug had U.S. sales of $14.3 million, according to QuinitlesIMS data.

  • Thrifty White Pharmacy is improving patient outcomes through new diabetes pilot

    PLYMOUTH, Minn. — Thrifty White Pharmacy is making a significant difference in patient lives through its new diabetes care program, which places recipients into a medsync program replete with comprehensive medication therapy management sessions, patient disease management goal setting and follow through. Thrifty White also offers a compliance packaging service, HealthyPack Rx, that helps organize and manage a patient's medication.

  • BD intros 6-mm pen needle for injection pens

    FRANKLIN LAKES, N.J. — BD is bringing a new option for patients using pen injection devices. The BD Ultra-Fine micro pen needle 6 mm x 32 gauge is set for distribution in September, bringing a new needle length option to patients with diabetes who inject insulin.

  • Health Dialog to host webinar on shared decision making

    BOSTON, Mass.— Rite Aid's Health Dialog on Monday announced it will host a complimentary webinar, “Five tactical steps for successful implementation of shared decision making,” on Sept. 20 at 1 p.m.

    Peter Goldbach, the company’s chief medical officer and a national authority on SDM, will provide strategic advice to help organizations execute effective shared decision making programs that reduce costs, improve outcomes and increase patient satisfaction.

X
This ad will auto-close in 10 seconds